When PKD Advances: How Dialysis or Kidney Transplant Planning Begins Before It Is Urgent

Key Takeaways
- Kidney failure is generally defined as an eGFR below 15, but PKD planning conversations usually begin once eGFR falls below about 30.
- A hemodialysis fistula needs roughly 2 to 3 months to mature, which is a major reason access surgery is scheduled well before dialysis is needed.
- People can be listed for a deceased-donor kidney transplant at an eGFR of 20 or below, and waiting time is commonly measured in years.
- PKD cysts do not form in a transplanted kidney because the gene variant lives in the recipient's own kidney cells, not the donor organ.
- ADPKD affects about 1 in 400 to 1,000 people and is the most common inherited kidney disorder, while ARPKD affects about 1 in 20,000 children.
- A sudden, severe headache in someone with ADPKD is an emergency because the condition increases the chance of a brain aneurysm.
As polycystic kidney disease advances, planning for dialysis or a kidney transplant usually begins when kidney function falls into the later stages of chronic kidney disease, often years before treatment is needed. Nephrologists use eGFR trends, kidney size, symptoms and family history to time referrals for transplant evaluation, dialysis access surgery and education, so the eventual decision is made calmly rather than in an emergency.
The appointment was supposed to be routine. Blood pressure, a blood draw, the usual questions about back pain and how much water she was drinking. Then her nephrologist turned the screen around and pointed to a line sloping gently downward: eGFR, a number that estimates how well the kidneys filter, sitting in the mid-20s. “Nothing is happening this year,” the doctor said. “But this is when we start talking.”
That conversation, about polycystic kidney disease dialysis or transplant planning, arrives for many families long before anything feels urgent. The kidneys are still working. Life looks the same from the outside. Yet the timing of that talk is one of the most consequential things a kidney team does.
This explainer walks through what “advancing” actually means in PKD, how the two replacement options work, who is steered toward which path and why, and what the first weeks of each tend to look like. It also corrects a few myths that make this stage harder than it needs to be.
What does it mean when polycystic kidney disease advances?
Polycystic kidney disease is an inherited condition in which fluid-filled sacs, called cysts, grow inside the kidneys and slowly crowd out working tissue. The kidneys enlarge over decades, sometimes reaching several times their normal size, while the number of functioning filtering units falls.
“Advancing” is measured mostly by one number: the estimated glomerular filtration rate, or eGFR, a calculation from a blood test that reflects how much blood the kidneys clean each minute. A healthy young adult typically sits above 90. Chronic kidney disease is divided into five stages, and kidney failure, the point where the kidneys can no longer keep a person well on their own, is generally defined as an eGFR below 15 or the need for dialysis or transplant (NIDDK).
PKD is unusual among kidney diseases for how predictable this decline can be. Cyst growth begins in childhood, but eGFR often stays normal into a person’s 30s or 40s because the kidney has spare capacity. Once that reserve is used up, function tends to drop in a fairly steady line. The NIDDK notes that roughly half of people with the common adult form, autosomal dominant PKD (ADPKD), develop kidney failure by about age 70.
Two features matter for planning beyond the eGFR itself. The first is total kidney volume, measured on ultrasound or MRI, because larger kidneys at a younger age tend to signal faster progression. The second is the trend line: a person whose eGFR falls a few points each year has a runway that can be sketched out with reasonable confidence, which is exactly why teams start the conversation early rather than waiting for symptoms.
Why polycystic kidney disease dialysis or transplant planning starts years early
It seems counterintuitive to discuss replacing a kidney that still works. The logic becomes clear once you look at how long each preparation step takes.
A transplant evaluation, the series of tests confirming someone is medically ready for surgery, can stretch over months. In the United States, people can be placed on the deceased-donor waiting list once eGFR is 20 or lower, and waiting time is commonly measured in years (NIDDK). Starting that clock early, while a person is still well, can mean a transplant becomes possible before dialysis is ever needed, an approach called pre-emptive transplantation.
Dialysis has its own lead time. A fistula, a surgical connection between an artery and a vein in the arm that allows blood to be drawn and returned during hemodialysis, needs roughly 2 to 3 months to mature before it can be used (NIDDK). A peritoneal dialysis catheter placed in the abdomen also needs weeks to heal. If these steps happen only after kidney failure arrives, treatment often begins through a temporary catheter in a neck vein, which carries higher infection risk.
PKD adds its own reasons for early planning. Very large cystic kidneys can take up so much room in the abdomen that a surgeon must consider removing one or both before a transplanted kidney can fit, a decision that needs careful sequencing. People with a family history of brain aneurysm may be offered imaging before major surgery (Mayo Clinic). Cysts in the liver, common in ADPKD, can influence anesthesia and surgical planning.
Most guidelines therefore encourage education about all options once eGFR falls below about 30 (stage 4), with the goal of a chosen, prepared start rather than an urgent one.
How does dialysis actually work?
Dialysis does two of the kidney’s jobs artificially: it removes waste products and extra fluid from the blood, and it helps balance salts such as potassium. It does not replace the kidney’s hormone functions, which is why people on dialysis often still need treatment for anemia and bone health.
Hemodialysis routes blood out of the body, through a filter called a dialyzer, and back again. Inside the dialyzer, blood flows on one side of a thin membrane while a cleaning fluid flows on the other; wastes cross the membrane by diffusion, and fluid is pulled off by pressure. In-center hemodialysis is typically done three times a week for about four hours per session (NIDDK). Home hemodialysis allows more frequent, sometimes shorter, sessions after training.
Peritoneal dialysis uses the lining of the abdomen, the peritoneum, as the membrane. A soft catheter is placed through the abdominal wall, and a sterile fluid is run in, left for several hours to absorb wastes, then drained. Exchanges can be done by hand several times a day or by a machine overnight while a person sleeps (NIDDK).
For PKD specifically, the abdomen is the point of debate. Kidneys enlarged to many times their normal size leave less space for dialysis fluid and can make hernias more likely, so some teams are cautious about peritoneal dialysis when kidneys are very large. Others find it works well with adjusted fluid volumes. This is a case-by-case judgment based on imaging and examination, not a blanket rule, and it is one of the reasons early conversation matters.
Neither form of dialysis slows the underlying cyst growth; both simply stand in for lost filtering.
How does an ADPKD kidney transplant work?
A kidney transplant places a single healthy kidney from another person into the lower abdomen, connecting its blood vessels to the recipient’s pelvic vessels and its drainage tube, the ureter, to the bladder. The person’s own kidneys are usually left in place unless there is a specific reason to remove them.
Donor kidneys come from two sources. A deceased donor kidney is allocated through a national system based on blood group, tissue matching, time on the list and other factors. A living donor kidney comes from a relative, friend or even a stranger who volunteers; living-donor transplants can be scheduled in advance and tend to start working sooner (NIDDK). In PKD families, potential living donors who are blood relatives are usually screened with imaging and sometimes genetic testing to be sure they do not carry the condition themselves.
After surgery, the body’s immune system recognizes the new kidney as foreign. Anti-rejection medicines, a class known as immunosuppressants, dampen that response and are taken for as long as the kidney functions. The mechanism is a trade-off: less rejection, but a somewhat higher risk of infection and certain cancers, which is why transplant teams monitor closely for years. Your transplant team decides the specific regimen and adjusts it over time.
One reassuring point for PKD: the disease is caused by a gene variant in the person’s own kidney cells, so cysts do not form in the transplanted kidney. The new organ is not “caught” by PKD.
What a transplant does not do is fix other organs already affected. Liver cysts, if present, remain, and blood pressure still needs attention. The NIDDK describes transplant as the treatment that most closely restores normal kidney function, while emphasizing that it is a treatment, not a one-time fix.
Who is usually offered transplant first, and who is asked to wait?
Nearly every guideline treats kidney transplant as the preferred option for people who are medically suitable, because it frees the person from dialysis schedules and more fully restores kidney function (NIDDK). “Medically suitable” is where the nuance lives.
People commonly steered toward early transplant evaluation include those whose eGFR is approaching 20, those with a willing potential living donor, and those without serious heart, lung or vascular disease that would make major surgery unsafe. Age alone is not a barrier; fitness for surgery is what matters.
People asked to wait, or to start dialysis first, tend to fall into a few groups:
- Those with an active infection, including an infected kidney cyst, which must be fully treated before immunosuppression.
- Those with a recent cancer, where a disease-free interval is usually required before a transplant is considered.
- Those with untreated or unstable heart disease, since the operation and the medicines afterward place demands on the cardiovascular system.
- Those whose cystic kidneys are so large that a nephrectomy, surgical removal of one or both kidneys, must come first to make room, which adds a recovery period.
- Those whose eGFR is still above the listing threshold; they are typically educated and monitored, not yet listed.
Being asked to wait is not the same as being turned down. Transplant teams re-evaluate as circumstances change, and dialysis can serve as a bridge for months or years. The decision about sequence sits with the treating nephrologist and transplant team together, informed by imaging, heart testing and the person’s own priorities.
Dialysis versus transplant in PKD: a side-by-side view
People at this stage often ask for the options laid out plainly. The table below summarizes what mainstream guidance describes, with PKD-specific considerations noted. It is a starting point for discussion, not a scorecard, since the right fit depends on the individual.
| Option | What it involves | Typical schedule | PKD-specific considerations |
|---|---|---|---|
| In-center hemodialysis | Blood filtered through a machine via fistula, graft or catheter | About 3 sessions a week, roughly 4 hours each (NIDDK) | Fistula needs 2–3 months to mature; large kidneys do not usually interfere |
| Home hemodialysis | Same principle, done at home after training | More frequent, often shorter sessions | Requires space, a trained partner in many programs |
| Peritoneal dialysis | Fluid exchanged through an abdominal catheter | Daily, by hand or overnight machine (NIDDK) | Very large kidneys may limit fluid volume; hernia risk assessed |
| Kidney transplant (living donor) | Scheduled surgery placing a donor kidney | One operation, lifelong medication and follow-up | Related donors screened for PKD; can be pre-emptive |
| Kidney transplant (deceased donor) | Surgery when a matched kidney becomes available | Waiting often measured in years (NIDDK) | Listing possible at eGFR 20 or below; nephrectomy sometimes needed first |
| Conservative kidney management | Symptom control without dialysis or transplant | Ongoing clinic care | Chosen by some people with other serious illness or personal preference |
A few observations from the evidence stand behind the table. Transplant offers the most complete restoration of kidney function and the fewest restrictions on daily life, which is why guidelines prefer it when possible (NIDDK). Peritoneal dialysis and home hemodialysis offer flexibility and independence. In-center hemodialysis asks the least of a household in terms of training and equipment. Conservative management is a legitimate, supported choice rather than “giving up,” and good kidney teams present it alongside the others.
PKD-specific questions: kidney size, nephrectomy and aneurysm screening
Three planning issues are almost unique to PKD, and they explain why this disease gets its own transplant pathway in many programs.
The first is sheer size. Cystic kidneys can each weigh several kilograms, compared with roughly 150 grams for a normal kidney. A surgeon needs room in the lower abdomen to place a new kidney and connect it safely. When imaging shows a native kidney extending down into the pelvis, the team may recommend removing that kidney, either weeks to months before transplant or during the same operation. The trade-offs differ: removal beforehand means a second surgery but a clearer field; removal at the same time means one anesthetic but a longer, more complex procedure. Neither approach is universally better, and the choice depends on anatomy, the person’s general health and the program’s experience.
The second is infection and bleeding. Cysts can become infected or bleed, causing pain, fever or blood in the urine. Recurrent, hard-to-clear cyst infections are another reason a native kidney may be removed before immunosuppression begins, since suppressing the immune system with an infected organ in place is risky.
The third is the brain. ADPKD is associated with an increased chance of intracranial aneurysm, a weak bulge in a brain artery. Mayo Clinic notes that screening imaging is usually considered for people with a family history of aneurysm or before major surgery. Finding and managing an aneurysm beforehand is a safety step, not an indication that surgery is off the table.
Liver cysts, present in many adults with ADPKD, rarely affect liver function but can make the abdomen crowded and occasionally need their own treatment. Your team will weigh all of these together; none is a reason to delay the initial conversation.
Can medicines slow PKD before dialysis or transplant is needed?
For decades the honest answer was no: treatment meant controlling blood pressure and waiting. That has shifted, though the shift is more modest than headlines sometimes suggest.
Blood pressure control remains the foundation. High blood pressure develops early in ADPKD, often before eGFR falls, and it accelerates kidney damage. Medicines in the ACE inhibitor and angiotensin receptor blocker classes relax blood vessels by acting on the renin-angiotensin system, and they are commonly used as first-line agents in kidney disease (NIDDK). The target and the choice belong to the prescribing clinician.
The one medicine specifically approved for ADPKD is tolvaptan, a vasopressin receptor antagonist. Vasopressin is a hormone that normally tells the kidney to hold onto water; in PKD it also stimulates the cells lining cysts to grow and secrete fluid. Blocking its receptor slows that signal. In clinical trials, tolvaptan slowed the rate of kidney enlargement and the decline in eGFR in adults judged to be at risk of rapid progression (NHS). It did not stop the disease, and it is not suitable for everyone: it causes marked thirst and frequent urination, and it requires regular liver blood tests because of a risk of liver injury (NHS). Whether it is appropriate, and for how long, is a decision for a nephrologist who knows the person’s kidney size, eGFR trend and other conditions.
What the evidence does not support is any supplement, herbal product or restrictive regimen marketed as shrinking cysts. No such product has demonstrated benefit in controlled trials, and some can harm kidneys or interact with prescribed medicines. If a person is already taking a prescribed medicine, this article is not a reason to change it; that conversation belongs with the prescriber.
What is the best diet for polycystic kidney disease as function declines?
Diet cannot reverse PKD, but it can protect the remaining kidney tissue and reduce the strain of high blood pressure. The advice shifts as eGFR falls, which is why a kidney dietitian is part of most advanced-care teams.
Water is the most PKD-specific item. Because vasopressin drives cyst growth and the body releases vasopressin when it senses dehydration, keeping well hydrated may help suppress that signal. NIDDK guidance for PKD encourages drinking plenty of water throughout the day, though the ideal amount has not been settled by trials, and people with advanced kidney disease or on dialysis may be asked to limit fluid instead. This is a clear example of advice that reverses depending on stage, so it should come from your team.
Salt matters at every stage. Lowering sodium helps blood pressure medicines work and reduces fluid retention (NIDDK). Practically, that means fewer processed and restaurant foods, since most dietary sodium comes from packaged products rather than the salt shaker.
Protein is more nuanced. Very high protein intake increases the kidney’s workload, so moderate intake is generally advised in chronic kidney disease. Once dialysis begins, protein needs often rise because some is lost during treatment. Again, the direction changes with stage.
As eGFR falls into stage 4 and 5, potassium and phosphorus may need attention, because the kidneys clear them less efficiently. Blood tests guide whether limits are needed; blanket avoidance of fruits and vegetables is not recommended without evidence of high levels.
What the evidence does not support: ketogenic or extreme low-carbohydrate diets promoted online for PKD. Early research exists, but no major guideline endorses them, and they carry risks in kidney disease. Ask before trying anything restrictive.
Is polycystic kidney disease hereditary, and is it considered rare?
Both questions come up constantly when planning begins, partly because a transplant workup often prompts relatives to ask about their own risk.
PKD is genetic. The common adult form, ADPKD, is autosomal dominant, meaning a person needs only one altered copy of the gene, usually PKD1 or PKD2, to develop the condition. Each child of an affected parent has a 50 percent chance of inheriting it (MedlinePlus). About one in ten people with ADPKD have no affected parent; their variant arose new. The rarer childhood form, autosomal recessive PKD (ARPKD), requires two altered copies and often causes problems in infancy.
As for rarity, the answer depends on which form you mean. NIDDK describes ADPKD as the most common inherited kidney disorder, affecting roughly 1 in every 400 to 1,000 people. That is not rare by the usual US definition of fewer than 200,000 affected people; it is uncommon but familiar to every nephrologist. ARPKD, by contrast, affects about 1 in 20,000 children (NIDDK) and does meet rare-disease criteria.
Family screening is a personal decision with real implications. Imaging can detect cysts in adult relatives, and genetic testing can clarify uncertain cases or identify which variant a family carries. Knowing early allows blood pressure to be watched from a young age. It can also affect insurance, employment and emotional wellbeing, so genetic counseling is usually offered before testing, especially for young adults who feel well.
For living donation, screening becomes essential: a relative who wishes to donate must be shown not to carry the condition. Programs have specific protocols for this, and the transplant team, not the family, decides when a potential donor has been adequately cleared.
What do the first weeks of dialysis or transplant usually look like?
The two paths feel very different in the early weeks, and knowing what to expect takes away some of the dread.
For hemodialysis, the first step is usually access surgery, an outpatient procedure lasting an hour or two. The arm is sore for days, and the fistula is then left to mature for roughly 2 to 3 months while a person learns to feel the characteristic buzz, called a thrill, over the vein (NIDDK). When treatment starts, the initial sessions are often shorter as the body adjusts. Fatigue after sessions, cramping and headaches are common early on and usually ease as the team fine-tunes fluid removal. Most people are asked to protect the access arm from blood pressure cuffs and needles for life.
For peritoneal dialysis, the catheter is placed and then allowed to heal for about two weeks before use. Training follows, typically over one to two weeks, covering sterile technique and troubleshooting. The main adjustment is a daily routine at home rather than travel to a center.
For transplant, the hospital stay after surgery is typically several days, with drains, a urinary catheter and close monitoring of urine output and kidney function (NIDDK). Some transplanted kidneys start working immediately; others take days or weeks and may need temporary dialysis support, which is not a sign of failure. The first three months involve frequent clinic visits and blood tests, sometimes several a week at first, to adjust anti-rejection medicines. Lifting is restricted for several weeks while the incision heals, and infection precautions are emphasized because immunosuppression is highest early. Most people return to usual activities within one to two months, though the timeline is individual and set by the surgical team.
What people often get wrong about polycystic kidney disease dialysis or transplant
Myths at this stage are rarely foolish; they usually come from outdated information or from mixing up different kidney diseases. A few deserve correction.
“If they are talking about dialysis, it must be imminent.” Not so. Education begins in stage 4, and many people remain there for years. The conversation is about preparation, not a countdown.
“PKD will grow in the new kidney.” It will not. The gene variant lives in the person’s own kidney cells; a donor kidney without the variant does not form PKD cysts (Mayo Clinic).
“Dialysis is a lifelong sentence once started.” Dialysis is frequently a bridge to transplant. People move off dialysis when a kidney becomes available, and some move back if a transplant eventually fails. It is a tool, not a verdict.
“Older people are not eligible for transplant.” Programs assess fitness, not birth date. Many people in their 60s and 70s are transplanted after evaluation shows their heart and blood vessels can tolerate surgery (NIDDK).
“Both kidneys always have to come out.” Most people keep their native kidneys. Removal is reserved for specific reasons: lack of space, recurrent infection or bleeding, or intractable pain.
“Kidney failure means the end.” Kidney failure is a treatable state. People live for decades on dialysis and after transplant, working, traveling and raising families. The disease is serious, and it is also one of the more predictable and plannable conditions in nephrology.
“Drinking gallons of water will shrink the cysts.” Hydration is sensible earlier in the disease, but no trial has shown that water alone reverses cyst growth, and excessive fluid can be dangerous once kidney function is low. Follow the target your team sets.
Questions to ask your care team about PKD kidney failure timing and options
Appointments at this stage are dense, and it is easy to leave without the answers that matter to you. Bringing written questions changes the dynamic. These are the ones nephrologists say they wish more people asked.
- What is my eGFR trend over the past two to three years, and what does that suggest about timing?
- How large are my kidneys on imaging, and would size affect peritoneal dialysis or transplant surgery?
- Am I a candidate for transplant evaluation now, and what tests would that involve?
- Do I have anyone in my life who might be considered as a living donor, and how would a relative be screened for PKD?
- Would you recommend removing one or both of my kidneys before transplant, and why or why not?
- Should I have brain imaging before any major surgery, given my family history?
- Which dialysis options are realistic for my home, work and abdomen, and what would each require me to learn?
- When would you want access surgery scheduled, and how long before it could be used?
- Is there a medicine to slow my PKD that fits my situation, and what monitoring would it need?
- What should my fluid, salt and protein targets be right now, and how will they change?
- Is conservative kidney management something we should discuss alongside dialysis and transplant?
- Who do I call, and when, if I develop fever, severe flank pain or blood in my urine?
Ask, too, whether a kidney dietitian, social worker and transplant coordinator are part of your team; each covers ground a nephrologist cannot cover in a fifteen-minute visit. If an answer is uncertain, a good clinician will say so and explain what would clarify it. The decisions remain shared, but the final recommendation rests with the treating team who can see your imaging, bloodwork and history together.
When to call your doctor: red-flag signs in advancing PKD
Planning is meant to be calm, but PKD can produce sudden problems that need same-day attention, and some need emergency care. Knowing the difference is part of living safely with the disease.
Seek emergency care immediately for a sudden, severe headache unlike any before, especially with a stiff neck, vomiting, confusion or fainting. Because ADPKD raises the chance of a brain aneurysm, this pattern must be checked urgently (Mayo Clinic). Call emergency services as well for chest pain, severe shortness of breath, or a sudden inability to pass urine.
Contact your kidney team the same day for fever with flank or abdominal pain, which can signal an infected cyst or kidney infection; for visible blood in the urine that does not settle within a day or two, or that comes with clots or heavy bleeding; for new or rapidly worsening swelling in the legs, ankles or face; for persistent vomiting that prevents you from keeping down fluids or medicines; or for a sudden drop in how much urine you pass.
If you already have dialysis access, call promptly if the arm becomes red, hot or painful, if the buzz over a fistula disappears, or if a catheter site leaks or shows pus. After transplant, report fever, pain over the new kidney, reduced urine output or a sudden weight gain without delay; these can be early signs of rejection or infection, both of which are far more manageable when caught early (NIDDK).
Between visits, keep a note of your blood pressure readings and any new symptoms. A brief message to the clinic about something that turns out to be minor is always preferable to waiting on something that is not. Your team would rather hear from you.
Frequently asked questions
What is the survival rate for people with polycystic kidney disease?
There is no single survival rate, because outcomes depend on age at kidney failure, blood pressure control, heart health and which replacement treatment a person receives. PKD progresses slowly, and many people live for decades on dialysis or with a transplant. Guidelines describe transplant as the option that most fully restores kidney function. Your nephrologist can give an individual picture based on your eGFR trend and overall health rather than a population statistic.
At what age does PKD usually cause kidney failure?
It varies widely, even within one family. The NIDDK notes that about half of people with ADPKD develop kidney failure by around age 70, which means many reach it earlier and many never do. Larger kidney volume at a younger age, early high blood pressure and certain gene variants are linked to faster decline. Because the trend is fairly predictable once eGFR starts falling, teams can often estimate a person’s likely timeline years ahead.
What are the early symptoms of polycystic kidney disease?
Many people have no symptoms for decades, and the first sign is often high blood pressure found at a routine check. Others notice back or side pain, headaches, blood in the urine, repeated urinary infections or kidney stones (MedlinePlus). None of these is specific to PKD, and their absence does not rule it out. If you have a family history, ask your doctor about screening rather than relying on symptoms.
What is the best diet for people with polycystic kidney disease?
The most consistent advice is to limit salt to help control blood pressure, keep protein moderate, and stay well hydrated earlier in the disease (NIDDK). As eGFR falls, potassium, phosphorus and fluid targets may change, sometimes in the opposite direction, so a kidney dietitian should guide you. No diet has been shown to shrink cysts, and restrictive regimens promoted online carry risks in kidney disease.
Is polycystic kidney disease hereditary?
Yes. ADPKD is passed down in an autosomal dominant pattern, so each child of an affected parent has a 50 percent chance of inheriting it (MedlinePlus). About one in ten cases arise from a new gene change with no affected parent. The childhood form, ARPKD, requires two altered gene copies. Genetic counseling is usually offered before testing relatives, and screening is required for any blood relative considering living donation.
Is PKD considered rare?
The adult form is not rare in the usual sense. NIDDK describes ADPKD as the most common inherited kidney disorder, affecting roughly 1 in 400 to 1,000 people, well above the US rare-disease threshold. The childhood form, ARPKD, affects about 1 in 20,000 children and does qualify as rare. Every nephrology practice sees ADPKD regularly, which is one reason its planning pathways are well established.
Can you have a kidney transplant with PKD without dialysis first?
Yes, when timing allows. This is called pre-emptive transplantation and is most often possible with a living donor, because the surgery can be scheduled before kidney failure arrives. Listing for a deceased-donor kidney can begin at an eGFR of 20 or below (NIDDK), though waiting times often mean dialysis starts first. Early referral for evaluation is what makes a pre-emptive transplant realistic.
Do PKD kidneys have to be removed before a transplant?
Usually not. Most people keep their native kidneys. Removal, called nephrectomy, is considered when kidneys are so large they leave no room for the new organ, when cysts repeatedly become infected or bleed, or when pain is severe. It may be done before or during transplant surgery, and the choice depends on anatomy and overall health. Your surgical team makes this recommendation after reviewing imaging.
Does polycystic kidney disease come back in a transplanted kidney?
No. PKD results from a gene variant in the person’s own kidney cells, so a donor kidney without that variant does not develop PKD cysts (Mayo Clinic). The transplanted kidney can face other problems, such as rejection or infection, which is why lifelong monitoring and anti-rejection medicines are needed. Liver cysts and blood pressure related to PKD still require ongoing attention after transplant.
Which dialysis is better for polycystic kidney disease?
Neither is universally better. Hemodialysis is unaffected by kidney size; peritoneal dialysis offers home flexibility but may be limited when very large kidneys crowd the abdomen or raise hernia risk. Lifestyle, home setup, vascular health and personal preference all weigh in. Guidelines encourage learning about every option, including transplant and conservative care, well before treatment is needed (NIDDK), and the final recommendation rests with your kidney team.
References
- NIDDK (NIH): Polycystic Kidney Disease
- NIDDK (NIH): Kidney Transplant
- NIDDK (NIH): Choosing a Treatment for Kidney Failure
- MedlinePlus: Polycystic kidney disease
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
More from the Blog
Varicocele Surgery for International Patients: Stay Length, Flying Home and Remote Follow-Up
People who travel for varicocele surgery are usually asked to stay near the surgical center until the first wound check, often within the first…
Preparing for a Kidney Ultrasound: Why You May Be Asked to Arrive With a Full Bladder
To prepare for a kidney ultrasound, most people are asked to drink water in the hour before the scan and to avoid emptying the…
Seeking a Second Opinion on Kidney Disease: What to Bring and What to Ask
A kidney disease second opinion is a review of your diagnosis, stage and treatment plan by another qualified clinician, usually a nephrologist. Bring your…
How Benign Prostatic Hyperplasia Progresses: Weak Flow, Night Waking and Planning Care Early
Benign prostatic hyperplasia (BPH) usually progresses slowly over years as the prostate enlarges and squeezes the urethra: a weaker, hesitant stream and more frequent…
Living With Overactive Bladder: Fluid Timing, Pelvic Floor Work and Sticking to Training
Living with overactive bladder usually starts with behavioral treatment: spacing fluids evenly through the day rather than cutting them, limiting caffeine and alcohol, practicing…
Common Misunderstandings About the PSA Test: A High Number Is Not a Diagnosis
A high PSA result is not a diagnosis of prostate cancer. PSA is a protein made by healthy and cancerous prostate cells alike, and…






